Search for: "Janssen v. Janssen"
Results 281 - 300
of 385
Sorted by Relevance
|
Sort by Date
14 Oct 2014, 2:48 pm
Jeremy Droege, et al. v. [read post]
1 May 2017, 8:00 am
Dolin, et al. v. [read post]
7 May 2012, 9:12 am
This bill, which was held in committee, was introduced to overturn Brody’s decision in Bassinger v. [read post]
4 Jan 2015, 8:18 am
Lynch v. [read post]
22 Oct 2021, 11:36 am
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
9 Feb 2015, 7:48 pm
Lynch v. [read post]
22 Oct 2021, 11:36 am
They argued that Johnson & Johnson/Janssen used cells ultimately derived from an aborted fetus to produce its vaccine, as did Moderna and Pfizer/BioNTech in researching their vaccines. [read post]
21 Apr 2017, 6:25 am
Brinckerhoff v. [read post]
6 May 2016, 8:00 am
Petrillo v. [read post]
29 Apr 2011, 7:43 am
Janssen Pharmaceutica Inc. [read post]
20 Mar 2017, 6:39 pm
In Bayer Pharma Aktiengesellschaft v Generic Health Pty Ltd [2017] FCA 250, Bayer was awarded damages of over $25m plus interest, assessed on Bayer’s pre-tax losses. [read post]
30 Aug 2021, 12:41 am
That Mellor J’s observations were not to be taken too generally was confirmed at a listing hearing in Teva v Janssen in August 2021 at which the former sought to list the trial in June 2022, 11 months after the claim form was issued. [read post]
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
17 Feb 2012, 11:29 am
Ortho-McNeil-Janssen Pharmaceuticals Inc., 2010 WL 3548474 (Pa. [read post]
3 Mar 2016, 5:19 am
See Larkin v. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan… [read post]
20 Mar 2015, 9:16 am
Wilson v. [read post]
30 Dec 2013, 5:25 am
Ge v. [read post]
5 Jul 2007, 10:37 am
Code §11-1-63(c)(ii); Janssen Pharmaceutica, Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Osgoode) Australia: University of Western Australia’s application to appeal FCAFC’s decision in University of Western Australia v Gray fails (IP Whiteboard) Colombia/EU/Peru: Tough IP health provisions in Europe’s Colombia/Peru trade deal (IP Watch) (IP tango) EU: Something more about Swiss type claims: G02/08 (SiNApSE) (SiNApSE) US: Pharmaceutical patent settlements – and what about patients? [read post]
